BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11297621)

  • 1. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
    Marsh DJ; Dahia PL; Coulon V; Zheng Z; Dorion-Bonnet F; Call KM; Little R; Lin AY; Eeles RA; Goldstein AM; Hodgson SV; Richardson AL; Robinson BG; Weber HC; Longy M; Eng C
    Genes Chromosomes Cancer; 1998 Jan; 21(1):61-9. PubMed ID: 9443042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.
    Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D
    Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
    Yeh JJ; Marsh DJ; Zedenius J; Dwight T; Delbridge L; Robinson BG; Eng C
    Genes Chromosomes Cancer; 1999 Dec; 26(4):322-8. PubMed ID: 10534767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple inositol polyphosphate phosphatase: evolution as a distinct group within the histidine phosphatase family and chromosomal localization of the human and mouse genes to chromosomes 10q23 and 19.
    Chi H; Tiller GE; Dasouki MJ; Romano PR; Wang J; O'keefe RJ; Puzas JE; Rosier RN; Reynolds PR
    Genomics; 1999 Mar; 56(3):324-36. PubMed ID: 10087200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.
    Gimm O; Perren A; Weng LP; Marsh DJ; Yeh JJ; Ziebold U; Gil E; Hinze R; Delbridge L; Lees JA; Mutter GL; Robinson BG; Komminoth P; Dralle H; Eng C
    Am J Pathol; 2000 May; 156(5):1693-700. PubMed ID: 10793080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
    Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
    Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.
    Eng C
    Recent Prog Horm Res; 1999; 54():441-52; discussion 453. PubMed ID: 10548886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.
    Marsh DJ; Zheng Z; Zedenius J; Kremer H; Padberg GW; Larsson C; Longy M; Eng C
    Cancer Res; 1997 Feb; 57(3):500-3. PubMed ID: 9012481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
    Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
    Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
    Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
    Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
    Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.